Barbara Weber, M.D.
Chairman
Tango Therapeutics, Inc. (TNGX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Barbara Weber, M.D.
Barbara Weber, M.D. is recorded as Chairman at Tango Therapeutics, Inc. (TNGX). Tango Therapeutics, Inc. reported in an 8-K filed January 8, 2026 that Barbara Weber, M.D. retired as Chief Executive Officer, effective January 8, 2026. Tango Therapeutics, Inc. reported in an 8-K filed January 8, 2026 that Barbara Weber, M.D. was appointed Executive Chair, effective January 8, 2026.
“today announced the retirement of its Chief Executive Officer, Dr. Barbara Weber, effective today January 8, 2026.”
“Dr. Weber has agreed to serve as the Company’s Executive Chair and to provide advisory services to assist in the orderly transition of her roles and responsibilities as President and Chief Executive Officer following the Effective Date through December 31, 2026.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-01-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tango Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Malte Peters CEO, Board Member
- Malte Peters, M.D. CEO
- Barbara Weber Chairman
- Matthew Gall CFO
- Jessica Newcomb Chief Accounting Officer
- James B. Avery Board Member
- John Ketchum Board Member
- Lesley Ann Calhoun Board Member
- Lesley Calhoun Board Member
- Mace Rothenberg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.